Showing results (881-890 of 1,193) with videos related to
Sort By:
Pageof 120
Pharmaceutical Statistics|May 22, 2019
Controlling for confounding via propensity score methods can result in biased estimation of the conditional AUC: A simulation studyHadiza I Galadima, Donna K McClishPharmaceutical Statistics|July 22, 2016
Bayesian predictive power: choice of prior and some recommendations for its use as probability of success in drug developmentKaspar Rufibach, Hans Ulrich Burger, Markus AbtPharmaceutical Statistics|April 28, 2015
Identification of drug-induced toxicity biomarkers for treatment determinationTzu-Pin Lu, James J ChenPharmaceutical Statistics|August 6, 2016
Choosing estimands in clinical trials with missing dataCraig Mallinckrodt, Geert Molenberghs, Suchitrita RathmannPharmaceutical Statistics|August 27, 2025
Design Considerations for a Phase II Platform Trial in Major Depressive DisorderMichaela Maria Freitag, Dario Zocholl, Elias Laurin Meyer, et al.Pharmaceutical Statistics|January 12, 2018
Approaches to sample size calculation for clinical trials in rare diseasesFrank Miller, Sarah Zohar, Nigel Stallard, et al.Pharmaceutical Statistics|December 29, 2017
Comparison of the restricted mean survival time with the hazard ratio in superiority trials with a time-to-event end pointBo Huang, Pei-Fen KuanPharmaceutical Statistics|February 27, 2007
Multiple-arm superiority and non-inferiority designs with various endpointsMark ChangPharmaceutical Statistics|November 4, 2006
Teaching statistics to clinical research staff in a pharmaceutical companySunil K Dhar, Farid KianifardPharmaceutical Statistics|March 14, 2007
Handling drop-out in longitudinal clinical trials: a comparison of the LOCF and MMRM approachesPeter LanePageof 120